Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Optimi Health Corp C.OPTI

Alternate Symbol(s):  OPTHF

Optimi Health Corp. is an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA), natural Manufacturing Practices (GMP)-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. The Company produces scalable... see more

Recent & Breaking News (CSE:OPTI)

Optimi Health Clears Final Base Shelf Prospectus

GlobeNewswire August 18, 2021

Optimi Health (CSE:OPTI) prepares for launch of online functional mushroom sales

John Ballem  August 10, 2021

Optimi Health Updates Launch of Online Functional Mushroom Sales

GlobeNewswire August 10, 2021

Optimi Health Strengthens Clinical and Regulatory Expertise

GlobeNewswire July 27, 2021

Optimi Health (CSE:OPTI) supports patient-focused Psilocybin advocacy by TheraPsil

Brieanna McCutcheon  June 29, 2021

Optimi Health (CSE:OPTI) engages U.S. based law firm for patent support

Brieanna McCutcheon  June 23, 2021

Optimi Health Engages U.S. Based Law Firm for Patent Support

GlobeNewswire June 23, 2021

Optimi Health Completes OTC Markets Uplisting to OTCQB

GlobeNewswire June 17, 2021

Optimi Health (CSE:OPTI) completes pre-clinical trial application meeting

Brieanna McCutcheon  June 15, 2021

Optimi Health Completes Pre-Clinical Trial Application Meeting

GlobeNewswire June 15, 2021

Optimi Health Announces Product Distribution Agreement with Vitasave

GlobeNewswire June 8, 2021

Optimi Health Announces DTC Eligibility & Up-List to OTCQB

GlobeNewswire June 3, 2021

Optimi Health Appoints Chief Science Officer

GlobeNewswire May 26, 2021

Optimi Health (CSE:OPTI) submits psilocybin extract to Health Canada

Simon Druker  May 11, 2021

Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

GlobeNewswire May 11, 2021

Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

GlobeNewswire May 4, 2021

Optimi Health (CSE:OPTI) finalizes planned build-out of mushroom production and research facility

Brieanna McCutcheon  April 27, 2021

Optimi Health Finalizes Planned Build-Out of Mushroom Production and Research Facility

GlobeNewswire April 27, 2021

Optimi Health (CSE:OPTI) adds to its corporate and advisory team

John Ballem  April 14, 2021

Optimi Health Adds to Corporate and Advisory Team

GlobeNewswire April 14, 2021